Insulin sensitivity in patients with primary aldosteronism: A follow-up study

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 9, 2006, Pages 3457-3463

  Catena, Cristiana ^a   Lapenna, Roberta ^a   Baroselli, Sara ^a   Nadalini, Elisa ^a   Colussi, GianLuca ^a   Novello, Marileda ^a   Favret, Grazia ^a   Melis, Alessandra ^a   Cavarape, Alessandro ^a   Sechi, Leonardo A ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADRENALECTOMY; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; IDIOPATHIC DISEASE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LABORATORY TEST; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

EID: 33748752420     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0736     Document Type: Article

References (36)

1. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z 1985 Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817
2. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S 1987 Insulin resistance in essential hypertension. N Engl J Med 317:350-357
3. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin R, Knowler WC, Bennet PH, Howard BV 1991 Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739
4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ 1996 Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957
5. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050
6. Gordon RD 2004 The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens 22:251-255
7. Sawka AM, Young Jr WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Herdeen JA 2001 Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135:258-261
8. Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G, Pacifico A 1990 Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension and with and without glucose metabolism impairment. Am J Hypertens 3:521-526
9. Shamiss A, Carrol J, Rosenthal T 1992 Insulin resistance in secondary hypertension. Am J Hypertens 5:26-28
10. Sechi LA, Melis A, Tedde R 1992 Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. Metabolism 41:1261-1266
11. Shimamoto K, Shiiki M, Ise T, Miyazaki Y, Higashiura K, Fukuoka M, Hirata A, Masuda A, Nagakawa M, Iimura O 1994 Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Hum Hypertens 8:755-759
12. Ishimori M, Takeda N, Okumura S, Murai T, Inouye H, Yasuda K 1994 Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin Endocrinol (Oxf) 41:433-438
13. Widimsky Jr J, Strauch B, Sindelka G, Skrha J 2001 Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol Res 50:603-607
14. Haluzik M, Sindelka G, Widimsky Jr J, Prazny M, Zelinka T, Skrh J 2002 Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 16:41-45
15. Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E 1997 Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA 277:1689-1695
16. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S 2000 Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 36:978-985
17. Ferrari P, Shaw SG, Nicod J, Saner E, Nussberger J 2004 Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertens 22:377-381
18. Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S 2002 Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 51:1226-1232
19. Reaven GM 2003 Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88:2399-2403
20. Allemann Y, Horber FF, Colombo M, Ferrari P, Shaw S, Jaeger P, Weidman P 1993 Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 341:327-331
21. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H 1992 Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20:797-801
22. Conn JW 1965 Hypertension, the potassium ion and impaired carbohydrate intolerance. N Engl J Med 273:1135-1143
23. 2003 The Expert Committee on the Diagnosis and Classification on Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification on Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5-S20
24. Sindelka G, Widimsky J, Haas T, Prazny M, Hilgertova J, Skrha J 2000 Insulin action in primary aldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 108:21-25
25. Strauch B, Widimsky J, Sindelka G, Skhra J 2003 Does the treatment of primary hyperaldosteronism influence glucose tolerance. Physiol Res 52:503-506
26. Skrha J, Haas T, Sindelka G, Prazny M, Widimsky J, Cibula D, Svacina S 2004 Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab 89:135-141
27. Widimsky J, Sindelka G, Haas T, Prazny M, Hilgertova J, Skrha J 2000 Impaired insulin action in primary hyperaldosteronism. Physiol Res 49:241-244
28. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P 2006 Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91:454-459
29. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, Valentini M, Tessari F, Ambrosiani E 2006 Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 24:837-843
30. Garcia-Puig J, Ruilope LM, Luque M, Fernandez J, Ortega R, Dal-Re R, AVANT Study Group Investigators 2006 Glucose metabolism in patients with essential hypertension. Am J Med 119:318-326
31. Falch DK, Schreiner A 1983 The effect of spironolactone on lipid, glucose and uric acid levels in blood during long-term administration to hypertensives. Acta Med Scand 213:27-30
32. Giacchetti G, Sechi LA, Rilli S, Carey RM 2005 The renin-angiotensin- aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 3:120-126
33. Henquin JC 2000 Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751-1760
34. Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB 1992 Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 19(Suppl 2):26-29
35. Corry DB, Tuck M 2003 The effect of aldosterone on glucose metabolism. Curr Hypertens Rep 5:106-109
36. Kraus D, Jager J, Meier B, Fasshauer M, Klein J 2005 Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res 37:455-459